Terms: = Colorectal cancer AND TOP2A, TOP2, TP2A AND Treatment
23 results:
1. Identification of Hub Genes for Psoriasis and cancer by Bioinformatic Analysis.
Yu Y; Ma S; Zhou J
Biomed Res Int; 2024; 2024():5058607. PubMed ID: 39045407
[TBL] [Abstract] [Full Text] [Related]
2. Identification of potential key genes for colorectal cancer based on bioinformatics analysis.
Li C; Cao S; Guo M; Guo A; Sun X
Medicine (Baltimore); 2023 Dec; 102(51):e36615. PubMed ID: 38134110
[TBL] [Abstract] [Full Text] [Related]
3. Potential Signature Therapeutic Biomarkers top2a, MAD2L1, and CDK1 in colorectal cancer: A Systems Biomedicine-Based Approach.
Priyamvada P; Ramaiah S
Biochem Genet; 2024 Jun; 62(3):2166-2194. PubMed ID: 37884851
[TBL] [Abstract] [Full Text] [Related]
4. Therapeutic targeting of the TPX2/TTK network in colorectal cancer.
Shaath H; Vishnubalaji R; Elango R; Velayutham D; Jithesh PV; Alajez NM
Cell Commun Signal; 2023 Sep; 21(1):265. PubMed ID: 37770979
[TBL] [Abstract] [Full Text] [Related]
5. [Risk factors for cancer-related cognitive impairment in breast and colorectal cancer patients who undergo chemotherapy].
Iranzo P; Callejo A; Arbej J; Menao S; Isla D; Andrés R
An Sist Sanit Navar; 2023 Aug; 46(2):. PubMed ID: 37594060
[TBL] [Abstract] [Full Text] [Related]
6. Network pharmacology and metabolomics elucidate the underlying mechanisms of Venenum Bufonis in the treatment of colorectal cancer.
Tao C; Wang J; Gu Z; Ni H; Luo Y; Ling J; Chen Y; Wu Y; Liu X; Zhou Y; Xu T
J Ethnopharmacol; 2023 Dec; 317():116695. PubMed ID: 37315651
[TBL] [Abstract] [Full Text] [Related]
7. Chalcone Derivative CX258 Suppresses colorectal cancer via Inhibiting the top2a/Wnt/β-Catenin Signaling.
Chen X; Lv X; Gao L; Liu J; Wang W; Guo L; Frasinyuk MS; Zhang W; Watt DS; Liu C; Liu X
Cells; 2023 Mar; 12(7):. PubMed ID: 37048139
[TBL] [Abstract] [Full Text] [Related]
8. Identification of a five genes prognosis signature for triple-negative breast cancer using multi-omics methods and bioinformatics analysis.
Ma J; Chen C; Liu S; Ji J; Wu D; Huang P; Wei D; Fan Z; Ren L
Cancer Gene Ther; 2022 Nov; 29(11):1578-1589. PubMed ID: 35474355
[TBL] [Abstract] [Full Text] [Related]
9. [Screening of differentially expressed genes for colorectal cancer and prediction of potential traditional Chinese medicine: based on bioinformatics].
Yun ZJ; Wang HJ; Yu YX; Sun ZY; Yao SK
Zhongguo Zhong Yao Za Zhi; 2022 Mar; 47(6):1666-1676. PubMed ID: 35347966
[TBL] [Abstract] [Full Text] [Related]
10. Integration of transcriptomics and metabolomics reveals anlotinib-induced cytotoxicity in colon cancer cells.
Jia Z; Zhang Z; Tian Q; Wu H; Xie Y; Li A; Zhang H; Yang Z; Zhang X
Gene; 2021 Jun; 786():145625. PubMed ID: 33798683
[TBL] [Abstract] [Full Text] [Related]
11. A data-driven approach to a chemotherapy recommendation model based on deep learning for patients with colorectal cancer in Korea.
Park JH; Baek JH; Sym SJ; Lee KY; Lee Y
BMC Med Inform Decis Mak; 2020 Sep; 20(1):241. PubMed ID: 32962726
[TBL] [Abstract] [Full Text] [Related]
12. The Indenoisoquinoline LMP517: A Novel Antitumor Agent Targeting both TOP1 and top2.
Marzi L; Sun Y; Huang SN; James A; Difilippantonio S; Pommier Y
Mol Cancer Ther; 2020 Aug; 19(8):1589-1597. PubMed ID: 32430490
[TBL] [Abstract] [Full Text] [Related]
13. Drug Design Targeting T-Cell Factor-Driven Epithelial-Mesenchymal Transition as a Therapeutic Strategy for colorectal cancer.
Abraham AD; Esquer H; Zhou Q; Tomlinson N; Hamill BD; Abbott JM; Li L; Pike LA; Rinaldetti S; Ramirez DA; Lunghofer PJ; Gomez JD; Schaack J; Nemkov T; D'Alessandro A; Hansen KC; Gustafson DL; Messersmith WA; LaBarbera DV
J Med Chem; 2019 Nov; 62(22):10182-10203. PubMed ID: 31675229
[TBL] [Abstract] [Full Text] [Related]
14. Targeted multiplex proteomics for molecular prescreening and biomarker discovery in metastatic colorectal cancer.
Serna G; Ruiz-Pace F; Cecchi F; Fasani R; Jimenez J; Thyparambil S; Landolfi S; Elez E; Vivancos A; Hembrough T; Tabernero J; Dienstmann R; Nuciforo P
Sci Rep; 2019 Sep; 9(1):13568. PubMed ID: 31537838
[TBL] [Abstract] [Full Text] [Related]
15. The identification of a common different gene expression signature in patients with colorectal cancer.
Zhao ZW; Fan XX; Yang LL; Song JJ; Fang SJ; Tu JF; Chen MJ; Zheng LY; Wu FZ; Zhang DK; Ying XH; Ji JS
Math Biosci Eng; 2019 Apr; 16(4):2942-2958. PubMed ID: 31137244
[TBL] [Abstract] [Full Text] [Related]
16. Topoisomerase expression and amplification in solid tumours: Analysis of 24,262 patients.
Heestand GM; Schwaederle M; Gatalica Z; Arguello D; Kurzrock R
Eur J Cancer; 2017 Sep; 83():80-87. PubMed ID: 28728050
[TBL] [Abstract] [Full Text] [Related]
17. Characterization of DNA topoisomerase I in three SN-38 resistant human colon cancer cell lines reveals a new pair of resistance-associated mutations.
Jensen NF; Agama K; Roy A; Smith DH; Pfister TD; Rømer MU; Zhang HL; Doroshow JH; Knudsen BR; Stenvang J; Brünner N; Pommier Y
J Exp Clin Cancer Res; 2016 Mar; 35():56. PubMed ID: 27029323
[TBL] [Abstract] [Full Text] [Related]
18. A phase II study of Epirubicin in oxaliplatin-resistant patients with metastatic colorectal cancer and top2a gene amplification.
Tarpgaard LS; Qvortrup C; Nygård SB; Nielsen SL; Andersen DR; Jensen NF; Stenvang J; Detlefsen S; Brünner N; Pfeiffer P
BMC Cancer; 2016 Feb; 16():91. PubMed ID: 26867764
[TBL] [Abstract] [Full Text] [Related]
19. Topoisomerase-1 and -2A gene copy numbers are elevated in mismatch repair-proficient colorectal cancers.
Sønderstrup IM; Nygård SB; Poulsen TS; Linnemann D; Stenvang J; Nielsen HJ; Bartek J; Brünner N; Nørgaard P; Riis L
Mol Oncol; 2015 Jun; 9(6):1207-17. PubMed ID: 25777966
[TBL] [Abstract] [Full Text] [Related]
20. Putative DNA/RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agents.
Zoppoli G; Regairaz M; Leo E; Reinhold WC; Varma S; Ballestrero A; Doroshow JH; Pommier Y
Proc Natl Acad Sci U S A; 2012 Sep; 109(37):15030-5. PubMed ID: 22927417
[TBL] [Abstract] [Full Text] [Related]
[Next]
